Securian Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $265K | Hold |
3,408
| – | – | 0.01% | 864 |
|
|
2026
Q1 | $192K | Hold |
3,408
| – | – | 0.01% | 895 |
|
|
2025
Q4 | $273K | Sell |
3,408
-200
| -6% | -$13.4K | 0.01% | 838 |
|
|
2025
Q3 | $176K | Sell |
3,608
-187
| -5% | -$11.6K | ﹤0.01% | 909 |
|
|
2025
Q2 | $283K | Hold |
3,795
| – | – | 0.01% | 849 |
|
|
2025
Q1 | $241K | Hold |
3,795
| – | – | 0.01% | 875 |
|
|
2024
Q4 | $296K | Sell |
3,795
-100
| -3% | -$8.03K | 0.01% | 850 |
|
|
2024
Q3 | $313K | Sell |
3,895
-100
| -3% | -$8.08K | 0.01% | 849 |
|
|
2024
Q2 | $331K | Sell |
3,995
-100
| -2% | -$8.8K | 0.01% | 816 |
|
|
2024
Q1 | $350K | Sell |
4,095
-200
| -5% | -$15.7K | 0.01% | 817 |
|
|
2023
Q4 | $367K | Hold |
4,295
| – | – | 0.01% | 805 |
|
|
2023
Q3 | $385K | Sell |
4,295
-191
| -4% | -$17.1K | 0.01% | 749 |
|
|
2023
Q2 | $382K | Sell |
4,486
-100
| -2% | -$8.46K | 0.01% | 782 |
|
|
2023
Q1 | $379K | Sell |
4,586
-100
| -2% | -$8.1K | 0.01% | 774 |
|
|
2022
Q4 | $369K | Hold |
4,686
| – | – | 0.01% | 779 |
|
|
2022
Q3 | $347K | Buy |
4,686
+116
| +3% | +$8.33K | 0.01% | 762 |
|
|
2022
Q2 | $298K | Hold |
4,570
| – | – | 0.01% | 877 |
|
|
2022
Q1 | $289K | Hold |
4,570
| – | – | 0.01% | 916 |
|
|
2021
Q4 | $242K | Hold |
4,570
| – | – | ﹤0.01% | 948 |
|
|
2021
Q3 | $323K | Sell |
4,570
-112
| -2% | -$7.07K | 0.01% | 887 |
|
|
2021
Q2 | $312K | Sell |
4,682
-131
| -3% | -$9.27K | 0.01% | 900 |
|
|
2021
Q1 | $534K | Hold |
4,813
| – | – | 0.01% | 745 |
|
|
2020
Q4 | $572K | Sell |
4,813
-110
| -2% | -$11.8K | 0.01% | 682 |
|
|
2020
Q3 | $430K | Sell |
4,923
-144
| -3% | -$12.6K | 0.01% | 731 |
|
|
2020
Q2 | $454K | Sell |
5,067
-100
| -2% | -$10.1K | 0.01% | 705 |
|
|
2020
Q1 | $515K | Hold |
5,167
| – | – | 0.01% | 619 |
|
|
2019
Q4 | $594K | Sell |
5,167
-531
| -9% | -$64.2K | 0.01% | 702 |
|
|
2019
Q3 | $719K | Sell |
5,698
-466
| -8% | -$59.1K | 0.02% | 657 |
|
|
2019
Q2 | $742K | Sell |
6,164
-50
| -0.8% | -$4.92K | 0.02% | 649 |
|
|
2019
Q1 | $544K | Sell |
6,214
-116
| -2% | -$10.5K | 0.01% | 753 |
|
|
2018
Q4 | $633K | Hold |
6,330
| – | – | 0.02% | 656 |
|
|
2018
Q3 | $725K | Sell |
6,330
-159
| -2% | -$16.5K | 0.02% | 671 |
|
|
2018
Q2 | $582K | Buy |
+6,489
| New | +$548K | 0.01% | 735 |
|
Other funds holding HAE
AI
Securian Asset Management's HAE Position: Q2 2026 in Review
Securian Asset Management held its Haemonetics (HAE) position steady in Q2 2026 at 3,408 shares worth $265K. The position accounts for 0.01% of the portfolio, ranked #864.
Securian Asset Management first reported a position in HAE in Q2 2018 and has held it in 33 quarters since. The position peaked at $742K in Q2 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Securian Asset Management held 3,408 shares of Haemonetics worth $265K as of Q2 2026.
- Securian Asset Management left its Haemonetics share count unchanged in Q2 2026.
- Haemonetics made up 0.01% of Securian Asset Management's portfolio in Q2 2026, its #864 holding.
- Securian Asset Management first reported a position in Haemonetics in Q2 2018 and has held it in 33 quarters since.
- Securian Asset Management's Haemonetics position peaked at $742K in Q2 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.